Publish date: 21 January 2022
Cheshire and Merseyside’s cancer hospital has appointed a new Director of Clinical Research to help drive the discovery of new and better treatment and care for cancer patients
Prof Christian Ottensmeier – a Consultant in Medical Oncology at The Clatterbridge Cancer Centre and Chair of Immuno-Oncology at the University of Liverpool (UoL) – has been given the role at the Clatterbridge Trust.
Prof Ottensmeier is an internationally recognised researcher into human immune responses to cancer and a Visiting Professor of Experimental Medicine at the University of Southampton, where he completed his PhD and spent much of his career before joining Clatterbridge, UoL and the Liverpool Head and Neck Centre in August 2020.
He also holds an Adjunct Professorship at the La Jolla Institute for Immunology in the USA and his latest research activity includes a portfolio of trials of new immunotherapies and among these he is the Principal Investigator for the Transgene trial, a first-in-class approach to making personalised therapeutic vaccines for head and neck cancers.
For more on this story, click here.